Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

AZ says Brilinta hits the mark in diabetic heart disease

The drug can reduce cardiovascular events in diabetics with CAD

- PMLiVE

Pharma industry swamped with no-deal Brexit info, says BIA

Deluge comes just as prime minister hints at delay

Visualising medicine

How creative can simplify the complex

- PMLiVE

Fireworks likely at Senate drug pricing hearing today

Senators fire broadsides: "I hope CEOs don't blame everyone but themselves"

- PMLiVE

Novartis and Syncona back new Swiss biotech Anaveon

Founders focused on IL-2 Receptor Agonists

- PMLiVE

FDA and Flatiron extend real world evidence collaboration

Roche-owned specialists at forefront of big data analysis

- PMLiVE

Lynparza scores against pancreatic cancer

AZ and MSD drug success in BRCA-mutated disease

- PMLiVE

Q&A: Nicola Walsby

Gemma Jones interviews Syneos Health's Managing Director PR UK

Doctors Letter

Health Literacy in Practice: Doctor’s Letter

If a patient was given their results directly, how could we make it into something they could understand and, most importantly, act on?

Cuttsy + Cuttsy

- PMLiVE

Combining therapies and combining research

The strategy for retaining antibiotic security

- PMLiVE

Three agencies join forces to form ONEHealth

Veronique Cotrel will head up the new agency

- PMLiVE

Ipsen buys rare disease group Clementia in $1.3bn deal

Will acquire lead multiple rare disease candidate palovarotene

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links